Expression of GnTIII in a recombinant anti‐CD20 CHO production cell line: Expression of antibodies with altered glycoforms leads to an increase in ADCC through higher affinity for FCγRIII
Davies, Julian, Jiang, LiYing, Pan, Li‐Zhen, LaBarre, Michael J., Anderson, Darrell, Reff, Mitchell·2001·Biotechnology and Bioengineering
DOI 10.1002/bit.1119
Cited by (327)
Items 301–327 of 327
- Antibody Posttranslational ModificationsRoy Jefferis · 2016
- Antibody GlycosylationRoy Jefferis · 2009
- Glycoengineering of Monoclonal AntibodiesCaterina Giorno · 2010
- Treatment with Monoclonal AntibodiesGisela M. Schwab, Lorin K. Roskos, Clay Davis · 2004 · Humana Press eBooks
- Optimization of Fc Domains to Enhance Antibody TherapeuticsGreg A. Lazar, Aaron K. Chamberlain · 2009 · Cambridge University Press eBooks
- Review Antibody engineering to develop new antirheumatic therapiesJohn Dudley Isaacs · 2009
- Engineered Antibody Derivatives in Preclinical and Clinical DevelopmentChristian Kellner, Matthias Peipp · 2013 · Springer eBooks
- Mechanisms of interferon-α inhibition by intravenous immunoglobulinALICE E. WIEDEMAN · 2013 · ResearchWorks at the University of Washington (University of Washington)
- A Novel Selection Technology for the Discovery of High-Affinity Human ProteinsDavid A. Busha · 2014 · CU Scholar (University of Colorado Boulder)
- Glycosylation patterns of human immunoglobulin G - recombinant IgG, vaccineinduced IgG and allo-immune specific IgGAnne Vestrheim · 2013 · NORA - Norwegian Open Research Archives
- Heterologous Expression of Lignocellulolytic Enzymes in Aspergillus nigerJinxiang Zhang, Yijun Huang, Huaming Wang · 2018 · Springer eBooks
- Towards the cell-free expression of glycoproteinsKealan Exley · 2017 · Spiral (Imperial College London)
- Glycoengineering of Chinese Hamster Ovary cells for improving biotherapeutics’ efficacies.Cheng‐Yu Chung · 2016
- Chemical Biology Study on N-glycansYoshiyuki Manabe · 2021 · Trends in Glycoscience and Glycotechnology
- Monoclonal Antibody Glycoengineering for Biopharmaceutical Quality AssuranceItzcóatl A. Gómez, Ioscani Jiménez del Val · 2021 · Cell engineering
- Prognostic value of plasma IgG N-glycome traits in patients with pulmonary arterial hypertension: an observational cohort studyZejian Zhang, Chao Liu, Jie‐Ling Ma, Jing-Si Ma, Jia Wang, Ruonan Li, Dan Lu, Yu‐Ping Zhou, Tian‐Yu Lian, Si-Jin Zhang et al. · 2023 · medRxiv
- Physicochemical and functional characterization of monoclonal antibodies for lot release (part 2)Harleen Kaur · 2024 · Elsevier eBooks
- Genetic Factors Affecting the Quality of Recombinant Therapeutic Proteins in CHO CellsChunliu Mi, Shao‐Lei Geng, Jingwen Xue, Qiu-li Sun, Wei-Hua Dong, Jihong Zhang, Qin Li, Xiao-Yin Wang, Tian-Yun Wang · 2025 · Biomacromolecules
- Analysis and improvement of bioactive polysaccharides裕之 綱島 · 2012
- Additional file 1 of Enhancement of effector functions of anti-CD20 monoclonal antibody by increased afucosylation in CHO cell line through cell culture medium optimizationBala Reddy Bheemareddy, Reddy, Prakash Narayana, Kranthi Vemparala, Vijaya ramu Dirisala · 2022 · Figshare
- N -Glycans as fundamental immune-checkpoints at the frontiers of inflammation, autoimmunity and cancerCatarina M. Azevedo, Beatriz Santos‐Pereira, Eduarda Leite-Gomes, C Tovim Rodrigues, Carolina S. Dantas, Guilherme Faria, Rafaela Nogueira, Pedro Almeida, Letícia Tavares-Gomes, Joana Gaifem et al. · 2025 · Royal Society of Chemistry eBooks
- Glycosylation control strategies for recombinant therapeutic proteins in CHO cellsWeifeng Wang, Weidong Li, Qianwen Wang, Xuekun Li, Tianyun Wang, Junhe Zhang · 2026 · Biochimie
- Core fucose: Molecular targets and functions in inflammatory signaling pathwaysYuki Ohkawa, Junpei Abe, Taiki Kuribara, Naoyuki Taniguchi · 2026 · Biochimica et Biophysica Acta (BBA) - General Subjects
- Mise en oeuvre de dosages pour le diagnostic précoce de l'hypothyroïdieChloé Iss · 2015 · theses.fr (ABES)
- Glycan Remodeling Technologies for Enhancing Antibody FunctionShino Manabe, Methanee Hiranyakorn · 2026 · Advances in experimental medicine and biology
- Les IgA anti VIH-1 protecteurs comme lien entre immunité innée et adaptative : recrutement et activation des cellules effectrices par des IgA anti-gp41 pour éliminer les cellules infectées par le VIH-1 et potentielle coopération avec les IgGMaxence Duchemin · 2020 · theses.fr (ABES)
- Immunoglobulines G de patients sclérodermiques : optimisation des méthodes de purification, étude de la glycosylation et analyse de l'impact sur le profil protéomique de fibroblastesLouisa Bourel · 2024